Insulin-like growth factor II mRNA binding protein 3 (IMP3) is overexpressed in prostate cancer and correlates with higher Gleason scores

URN to cite this document:: urn:nbn:de:bvb:355-epub-351808
DOI to cite this document:: 10.5283/epub.35180

Ikenberg, Kristian ; Fritzsche, Florian R. ; Zuerrer-Haerdi, Ursina ; Hofmann, Irina ; Hermanns, Thomas ; Seifert, Helge ; Müntener, Michael ; Provenzano, Maurizio ; Sulser, Tullio ; Behnke, Silvia ; Gerhardt, Josefine ; Mortezavi, Ashkan ; Wild, Peter ; Hofstädter, Ferdinand ; Burger, Maximilian ; Moch, Holger ; Kristiansen, Glen

Preview

License: Creative Commons: Attribution 3.0
PDF - Published Version
(1MB)

Date of publication of this fulltext: 09 Feb 2017 13:15

Alternative links to fulltext:DOI Publisher

Details

Preview

Export bibliographical data

Abstract

Background The oncofetal protein insulin-like growth factor II mRNA binding protein 3 (IMP3) is an important factor for cell-migration and adhesion in malignancies. Recent studies have shown a remarkable overexpression of IMP3 in different human malignant neoplasms and also revealed it as an important prognostic marker in some tumor entities. To our knowledge, IMP3 expression has not been ...